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S U M M A R Y
Background: Patients with acute-on-chronic liver failure (ACLF) are often highly susceptible to microbial
infection due to a depressed immune system. This study was carried out to investigate the prevalence
and clinical signiﬁcance of Cryptosporidium infection in patients with hepatitis B virus (HBV)-associated
ACLF in Hunan Province, China.
Methods: Fecal samples from 218 patients with HBV-associated ACLF, 122 patients with chronic
hepatitis B (CHB), and 140 children with diarrhea were collected; Cryptosporidium infection was
detected by auramine–phenol staining, modiﬁed acid-fast staining, and the polymerase chain reaction.
The clinical characteristics of this parasitic infection in Cryptosporidium-positive ACLF patients were
further evaluated.
Results: The prevalence of Cryptosporidium infection in the HBV-associated ACLF patients was 6.0% (13/
218), which was markedly higher than that found in CHB patients (0.8%, 1/122) and in children with
diarrhea (1.4%, 2/140). Although watery diarrhea was not seen in the 13 Cryptosporidium-positive ACLF
patients, eight (61.5%) of them had diarrhea. Moreover, our investigation showed that Cryptosporidium
infection was not associated with the severity of the disease in ACLF patients.
Conclusions: The prevalence of Cryptosporidium infection is high among patients with HBV-associated
ACLF and might be a signiﬁcant cause of diarrhea in this population.
 2011 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Cryptosporidium is a signiﬁcant cause of diarrheal diseases in
both developing and industrialized countries. Cryptosporidiosis is
mainly characterized by a clinical manifestation of six to eight
watery diarrhea episodes per day. Diarrhea caused by Cryptospo-
ridium infection is usually self-limiting in immunocompetent
humans, however it can be life-threatening in children and in the
immunocompromised. Since the ﬁrst report in 1976,1 Cryptospo-
ridium infection has been reported in various populations with
severe impairments of immune status, such as those with AIDS,2,3
acute leukaemia4 and other hematological disorders,5 interferon
deﬁciencies,6 graft transplants,7 and hospitalized and malnour-
ished children.8,9 Strikingly, in a study of HIV-infected patients,
over 37.3% of AIDS patients with diarrhea were found to have a
Cryptosporidium infection, which often worsened the prognosis of
the disease.10* Corresponding author. Tel.: +86 775 26553111-26402; fax: +86 755 26565025.
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doi:10.1016/j.ijid.2011.08.006Abundant evidence has indicated that the immune status is
impaired in patients with acute-on-chronic liver failure (ACLF),
who are often highly susceptible to microbial infection.11–15
Diarrhea is not uncommon in patients with ACLF, but the
prevalence of Cryptosporidium infection in this population
remains unknown. The purpose of this study was to determine
the prevalence and potentially clinical signiﬁcance of Cryptospo-
ridium infection in patients with hepatitis B virus (HBV)-
associated ACLF in Hunan Province, China.
2. Methods
2.1. Subjects
This study was conducted between August 2002 and August
2005. Fecal samples were collected from 218 patients with HBV-
associated ACLF, 122 patients with chronic hepatitis B (CHB), and
140 children aged under 2 years with diarrhea from Xiangya
Hospital in Hunan Province, China. Patients with HBV-associated
ACLF and CHB were diagnosed according to previously described
criteria.14,15 Late-stage ACLF was deﬁned in the presence of moreses. Published by Elsevier Ltd. All rights reserved.
Table 1
Clinical characteristics of the populations enrolled in the study
Group ACLF CHB Children with diarrhea
Number of cases 218 122 140
Sex (male/female) 23/195 15/107 30/110
Age (years), median (range) 38 (27–49) 39 (29–50) 1 (3 months–2 years)
ALT (U/l), median (range) 325 (55–1354) 655 (95–1895) 19 (6–35)
TBIL (mmol/l), median (range) 353.7 (179.5–765.4) 25.5 (9.5–35.9) 9.2 (6–35)
PTA, median (range) 31.2% (20.9–36.8%) 91.5% (71.9–122.5%) 103% (95–122.5%)
ACLF, acute-on-chronic liver failure; CHB, chronic hepatitis B; ALT, alanine aminotransferase; TBIL, total bilirubin; PTA, prothrombin activity.
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(such as severe hemorrhage, ascites, etc.).11 Patients were deﬁned
as having signs or symptoms of infection if they had elevated white
blood or neutrophil cell counts, the occurrence of spontaneous
peritonitis, evidence of organ infection (such as pneumonia,
urinary tract infection, pelvic cavity infection, etc.), or unknown
fever that was treatable with antibiotics. Recovery in patients with
ACLF was deﬁned as: (1) liver function with normal alanine
aminotransferase (ALT) and total bilirubin (TBIL) for 6 months; (2)
disappearance of clinical manifestations of liver failure after
routine treatment for 6 months. Patients with ACLF other than
those who had recovered or died were deﬁned as intractable cases.
All patients with ACLF and CHB were followed for 6 months, and
fecal samples were collected on days 10, 20, and 30 after the
diagnosis of ACLF or CHB; additional fecal samples were collected if
diarrhea occurred. Individuals with concurrent hepatitis C virus
(HCV), hepatitis E virus (HEV), hepatitis A virus (HAV), or HIV
infections or who had autoimmune liver diseases were excluded.
The characteristics of the various groups in this study are described
in Table 1. The research protocol was approved by the Ethics
Committee of Central South University, and written informed
consent was obtained from each subject.
Diarrhea was deﬁned as three or more unformed stools in a
24-h period. A patient was considered to be infected with
Cryptosporidium if it was detected positively by auramine–phenol
staining (APS), modiﬁed acid-fast staining (AFS), or polymerase
chain reaction (PCR).
2.2. Fixation and smear preparations
Stool samples were examined morphologically and microscop-
ically for consistency of their characteristics and for the appear-
ance of other parasites. A small amount of stool (30 g) was mixed
with 12 ml of ﬁxation buffer (12 ml of phosphate-buffered saline,
24 ml of formaldehyde, 120 ml of glycerin, and distilled water to
make the ﬁnal volume equal to 1200 ml), and incubated for 1 h at
room temperature to be ﬁxed and inactivated. The suspension was
passed through four layers of cotton netting and centrifuged at
2000 g for 5 min.16,17 Three smears were made from the pellet;
these were air-dried, ﬁxed with methanol and/or acetone, and then
examined by AFS and APS. In addition, 200 ml of each fecal
suspension was used to extract DNA and detect Cryptosporidium
infection by PCR. All chemicals were purchased from Sigma
Company, St. Louis, USA.
2.3. Modiﬁed acid-fast staining (AFS)
For AFS, ﬁxed smears were stained with carbol fuchsin and
heated (2–5 min on a candle ﬂame until dry), rinsed with tap
water, destained with 3% acid alcohol, restained for background
color with 0.5% malachite green (5 min), rinsed with tap water,
dried at room temperature, and examined under a microscope.
Cryptosporidium oocysts appeared as pink to red, spherical to
ovoid bodies using the AFS method, and a stool was consideredpositive for Cryptosporidium infection if typical oocysts of 5 mm
were observed using the Kinyoun technique.16,17 The intensity of
infection was estimated semi-quantitatively according to the
average number of oocysts in 20 randomly selected ﬁelds at 1000
magniﬁcation, and the categories established were: negative
(absence of oocysts), slight (1–5 oocysts), moderate (6–10 oocysts),
and severe (>10 oocysts).16
2.4. Auramine–phenol staining (APS)
For the APS assay, ﬁxed smears were stained with auramine O
(15 min), rinsed with tap water, destained with 3% acid alcohol,
restained for background color with 0.5% potassium permanganate
(3 min), rinsed with tap water, dried at room temperature, and
observed under a ﬂuorescence microscope.16,17
2.5. DNA extraction and PCR detection
For DNA isolation, DNA was extracted from all fecal suspensions
using a DNA Stool Mini Kit (Qiagen, Valencia, CA, USA) in accordance
with the manufacturer’s suggested protocol. The eluted DNA was
stored at 20 8C. PCR to detect the Cryptosporidium parvum was
carried out as previously described.18–20 PCR was performed using
the sense primer 50-CCGAGTTTGATCCAAAAAGTTACGAA-30 and the
antisense primer 50-TAGCTCCTCATATGCCTTATTGAGTA-30, and pro-
grammed as: 95 8C for 5 min, 35 cycles of 95 8C for 30 s, 55 8C for 40 s,
and 72 8C for 40 s. The ampliﬁed 452-bp fragment of PCR products
were separated on 1.5% agarose gels and visualized with ethidium
bromide staining. All PCR products were sequenced and analyzed on
an ABI 377 automated sequencer (Invitrogen Company,California,
USA) to conﬁrm their homology with genomic nucleotide sequence
107656–108107 of Cryptosporidium parvum Iowa II chromosome 8
(GenBank: NC_006987.1).18–20
2.6. Statistical analysis
The results of the study were analyzed using SPSS software v.
11.0 (SPSS, Chicago, IL, USA). The Chi-square test was used to
determine the relationship between the presence of Cryptospo-
ridium in patients who provided the stool samples and other
parameters, such as different symptoms and the correlated
characteristics. The Student’s t-test was used to compare groups
with continuous data measurement.
3. Results
3.1. Prevalence of Cryptosporidium infection in patients with ACLF
The prevalence of Cryptosporidium infection in patients with
HBV-associated ACLF was 6.0% (13/218), in CHB patients was 0.8%
(1/122), and in children with diarrhea was 1.4% (2/140) (Table 2).
Results show that the rate of positive Cryptosporidium infection in
HBV-associated ACLF patients was signiﬁcantly higher than that in
CHB patients and that in diarrheic children (p < 0.01 for both).
Table 2
Detection of Cryptosporidium infection by auramine–phenol staining, modiﬁed acid-fast staining, and polymerase chain reaction
Group n Stain with APS Stain with AFS Stain with APS and
AFSa





















ACLF 218 9 4.1% 7 3.2% 6 2.8% 13b 6.0% 13 6.0%c
CHB 122 1 0.8% 0 0 0 0 1b 0.8% 1 0.8%
Children with diarrhea 140 1 0.7% 1 0.7% 0 0 2b 1.4% 2 1.4%
ACLF, acute-on-chronic liver failure; CHB, chronic hepatitis B; APS, auramine–phenol staining; AFS, modiﬁed acid-fast staining; PCR, polymerase chain reaction.
a Positive by both APS and AFS.
b Including cases positive by APS and/or AFS.
c p < 0.01 vs. patients with CHB and children with diarrhea, respectively.
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with nucleotide sequence 107656–108107 of C. parvum Iowa II
chromosome 8 (GenBank: NC_006987.1), suggesting that all
patients in this study in Hunan Province, China were infected
with C. parvum.18–20
ACLF patients with Cryptosporidium infection showed no
intractable or watery diarrhea. All positive samples detected in
ACLF and CHB patients by AFS (n = 7) or APS (n = 10) only showed a
slight infection (1–5 oocysts/ﬁeld of magniﬁcation). However, one
diarrheic child had a severe infection (>10 oocysts/ﬁeld of
magniﬁcation). The intensity of infection as determined by the
number of oocysts found in ACLF patients showed no signiﬁcant
difference as compared to CHB patients (data not shown).
3.2. Clinical characteristics of Cryptosporidium infection in patients
with ACLF
Of the 218 patients with HBV-associated ACLF, 90 cases were
deﬁned as late-stage liver failure. The rate of positive Cryptospo-
ridium infection in patients with late-stage liver failure (7.8%, 7/
90) showed no signiﬁcant difference to that in patients not in the
late stage (4.7%, 6/128) (p > 0.05). Of the 90 patients with late-
stage ACLF, 25 cases died or had intractable disease and 65 cases
recovered. The rate of positive Cryptosporidium infection in the
recovered ACLF patients with late-stage liver failure (7.7%, 5/65)
showed no signiﬁcant difference compared with that in patients
without recovery (8%, 2/25) (p > 0.05), suggesting that the severity
of HBV-associated ACLF was not associated with Cryptosporidium
infection in our study.
However, the Cryptosporidium-positive rate in ACLF patients
complicated with infection (8.4%, 11/131) was signiﬁcantly higher
compared with that in patients without signs or symptoms of
infection (2.3%, 2/87) (p < 0.01), suggesting that Cryptosporidium
caused infection in ACLF patients.
Consistently, 61.5% (8/13) of the Cryptosporidium-positive
ACLF patients suffered with non-watery diarrhea, while only 24.4%
(50/205) of the Cryptosporidium-negative ACLF patients had
diarrhea (p < 0.01). Among all 218 ACLF patients, 58 had diarrhea
and eight of them were Cryptosporidium-positive (13.8%, 8/58),
which is signiﬁcantly higher than the Cryptosporidium-positive
rate in patients without diarrhea (3.1%, 5/160) (p < 0.01). In
addition, none of the 21 CHB patients with diarrhea were
Cryptosporidium-positive. Taken together, our data strongly
suggest that Cryptosporidium infection could be a cause of
diarrhea in patients with HBV-associated ACLF.
4. Discussion
It has been demonstrated that severe liver injury and liver
failure are closely associated with cellular immune depression.11
This reduced cellular immune function could contribute to an
increased susceptibility to microbial infection in subjects withACLF. Some reports have shown that Cryptosporidium is responsi-
ble for the majority of gastrointestinal parasitic infections in
immune compromised hosts.7,21 Gastrointestinal infections and
symptoms of diarrhea often occur in patients with HBV-associated
ACLF, however whether Cryptosporidium infection is involved in
these cases remains unknown.
Screening of stool sediment smears by APS and AFS is a sensitive
and speciﬁc approach for the identiﬁcation of Cryptosporidium
oocysts in stools. Some reports have shown that PCR is more
sensitive compared with APS and AFS.8,19 In this study, using these
three methods, 6.0% of patients with HBV-associated ACLF were
found to be infected with Cryptosporidium, and this prevalence
was signiﬁcantly higher than that in CHB patients and in children
with diarrhea. In developing countries, Cryptosporidium infection
occurs mostly in children younger than 5 years of age and in AIDS
patients.17,22,23 In this study in Hunan Province, a positive rate of
1.4% was determined for Cryptosporidium infection in children
with diarrhea aged younger than 2 years, which is consistent with
the ﬁndings in other Chinese reports (0.82–3.9%).17,22 Le et al.
recently reported a total Cryptosporidium infection rate of 4.25%
(9/212) in AIDS patients in southern China.23 These analyses
indicate that Cryptosporidium may be another important patho-
gen in ACLF patients.
With the use of genotyping tools, recent studies have shown
that ﬁve species of Cryptosporidium (Cryptosporidium hominis, C.
parvum, Cryptosporidium meleagridis, Cryptosporidium felis, and
Cryptosporidium canis) are responsible for most human infec-
tions.24,25 C. hominis and C. parvum are the most common species in
humans.24,26 Our PCR results show that all patients were infected
with C. parvum, suggesting that this might be the main species of
human Cryptosporidium infection in Hunan Province.
Many reports have indicated that patients with ACLF and CHB
have different immune statuses,11–13 which may explain the
signiﬁcant difference in the prevalence of Cryptosporidium infection
between these two groups of patients. Clinical analysis in this study
indicated that the rate of positive Cryptosporidium infection in the
recovered ACLF patients showed no marked difference to the rate in
patients who did not recover. Our data also suggested no marked
difference between those with late-stage disease and those with
early- or middle-stage disease. It is well known that Cryptosporidium
infection in AIDS patients can promote disease progression and
worsen the prognosis,10,23 however our investigation showed
Cryptosporidium infection was not correlated with the progression
or severity of ACLF. Nevertheless, Cryptosporidium infection occurred
in ACLF patients with signs or symptoms of infection. Furthermore,
eight (61.5%) of 13 Cryptosporidium-positive ACLF patients had
diarrhea and the rate of positive Cryptosporidium infection in the
ACLF patients with diarrhea was markedly higher than that in those
without diarrhea (13.8% vs. 3.1%). These results indicate that
Cryptosporidium infection might be a signiﬁcant cause of diarrhea
in patients with HBV-associated ACLF in Hunan Province, China. In
our study, all positively stained fecal sample slides from ACLF
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oocysts/ﬁeld of magniﬁcation) and none of 13 ACLF patients with
Cryptosporidium infection suffered intractable diarrhea or watery
diarrhea. These results indicate that the clinical signiﬁcance of
Cryptosporidium infection in these patients needs to be further
investigated. ACLF patients with Cryptosporidium infection received
no speciﬁc anti-Cryptosporidium treatment; it is necessary to
evaluate whether early treatment of Cryptosporidium infection
can shorten the hospitalization time and promote improvements in
liver function.
In conclusion, the prevalence of Cryptosporidium infection in
patients with HVB-associated ACLF was markedly high compared
with the prevalence in CHB patients and in children with diarrhea.
Our results also indicate that Cryptosporidium infection in ACLF
patients did not cause as great an illness as has been found in those
with HIV infection. However, Cryptosporidium infection might be
a signiﬁcant cause of diarrhea in patients with HBV-associated
ACLF in Hunan Province, China. The clinical signiﬁcance of this
parasitic infection needs to be further studied.
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